The9 Ltd
NCTY
Bit Digital
BTBT
TeraWulf
WULF
Digihost Technology
DGHI
BTCS Inc
BTCS
US Stock MarketDetailed Quotes
ENGN enGene Holdings
- 4.750
- +0.090+1.93%
Close Mar 27 16:00 ET
242.14MMarket Cap-3.51P/E (TTM)
4.830High4.493Low17.43KVolume4.734Open4.660Pre Close82.55KTurnover0.07%Turnover RatioLossP/E (Static)50.98MShares17.54352wk High0.97P/B116.19MFloat Cap4.20052wk Low--Dividend TTM24.46MShs Float47.170Historical High--Div YieldTTM7.23%Amplitude4.200Historical Low4.736Avg Price1Lot Size
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
enGene Holdings Stock Forum
enGene Reports Q1 Results: Strong Cash Position Funds Global Trial Expansion
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
Data from pivotal cohort demonstrate compelling clinical activity, consistent with Phase 1 results
Favorable tolerability profile with no drug-related discontinuations
Detalimogene's profile to date supports its potential as a foundational therapy for NMIBC
enGene to host a conference call to discuss preliminary data today at 8:00 a.m. ET
enGene Hold...
$Aptevo Therapeutics (APVO.US)$
$enGene Holdings (ENGN.US)$
$Trxade Health (MEDS.US)$
My next high risk investment is $WeBuy Global (WBUY.US)$. They have until Monday to get their stock over a 1.00 or delisting procedur...
No comment yet